James A Lederer Selected Research

Fibrin

10/2018

Frontline Science: Targeted expression of a dominant-negative high mobility group A1 transgene improves outcome in sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James A Lederer Research Topics

Disease

18	Burns 01/2021 - 06/2003
13	Wounds and Injuries (Trauma) 01/2024 - 09/2003
8	Sepsis (Septicemia) 05/2024 - 03/2004
8	Infections 01/2023 - 02/2008
6	Inflammation (Inflammations) 05/2024 - 02/2015
6	Neoplasms (Cancer) 01/2023 - 11/2011
5	Hemorrhage 01/2023 - 02/2006
3	Lupus Nephritis 01/2024 - 01/2019
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2024 - 10/2019
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 01/2022
2	COVID-19 12/2022 - 11/2020
2	Glioblastoma (Glioblastoma Multiforme) 09/2022 - 01/2022
2	Arthritis (Polyarthritis) 01/2022 - 01/2021
2	Osteoarthritis 01/2019 - 01/2018
2	Endotoxemia 10/2018 - 06/2014
2	Bacterial Infections (Bacterial Infection) 03/2016 - 02/2013
2	Bacterial Pneumonia 03/2016 - 01/2016
1	Macrophage Activation Syndrome 11/2023
1	Multiple Trauma (Multiple Injuries) 01/2023
1	Crush Injuries 01/2023
1	Opportunistic Infections (Opportunistic Infection) 01/2023
1	Cytokine Release Syndrome 12/2022
1	Glioma (Gliomas) 09/2022
1	Edema (Dropsy) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Necrosis 01/2022
1	Pneumonia (Pneumonitis) 01/2021
1	Acute Lung Injury 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 10/2019
1	Rheumatoid Arthritis 01/2019

Drug/Important Bio-Agent (IBA)

16	salicylhydroxamic acid (SHAM)IBA 01/2021 - 06/2003
13	CytokinesIBA 09/2022 - 08/2003
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
4	AntibodiesIBA 11/2020 - 08/2005
4	Interleukin-17 (Interleukin 17)IBA 09/2017 - 01/2016
4	AntigensIBA 09/2017 - 10/2003
3	OligodeoxyribonucleotidesIBA 01/2023 - 01/2016
3	InflammasomesIBA 12/2022 - 01/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 08/2003
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 08/2005
3	Interleukin-2 (IL2)IBA 12/2015 - 09/2003
3	LipopolysaccharidesIBA 03/2008 - 08/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2005 - 08/2003
2	Interferon Type IIBA 01/2024 - 11/2023
2	ChemokinesIBA 01/2023 - 01/2005
2	Toll-Like Receptor 9IBA 01/2023 - 10/2020
2	CPG-oligonucleotideIBA 01/2023 - 01/2016
2	Complement System Proteins (Complement)IBA 01/2023 - 01/2021
2	Ganciclovir (Cytovene)FDA LinkGeneric 09/2022 - 01/2022
2	Thymidine KinaseIBA 09/2022 - 01/2022
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 09/2003
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2019 - 09/2017
2	EndotoxinsIBA 10/2018 - 08/2012
2	Interleukin-22 (IL-22)IBA 09/2017 - 12/2016
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2016 - 02/2006
2	Protein Kinases (Protein Kinase)IBA 03/2016 - 08/2005
2	Interleukin-10 (Interleukin 10)IBA 05/2009 - 09/2003
2	SuperantigensIBA 04/2004 - 09/2003
1	Carbon MonoxideIBA 05/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2024
1	Peptides (Polypeptides)IBA 01/2023
1	Conditioned Culture MediaIBA 01/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	LeukotrienesIBA 01/2023
1	ceralasertibIBA 09/2022
1	ProdrugsIBA 09/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	fludarabineIBA 01/2022
1	duvelisibIBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Valacyclovir (Valtrex)FDA LinkGeneric 01/2022
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021
1	Immunoglobulin Fab FragmentsIBA 01/2021
1	EpitopesIBA 11/2020
1	ProteomeIBA 11/2020
1	NucleoproteinsIBA 11/2020
1	Neutralizing AntibodiesIBA 11/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	AutoantibodiesIBA 10/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Small Cytoplasmic RNAIBA 01/2019
1	pristane (pristan)IBA 01/2019
1	FibrinIBA 10/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2018
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2018
1	osteoblast cadherinIBA 01/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2017

Therapy/Procedure

7	Therapeutics 05/2024 - 10/2018
6	Punctures 01/2023 - 06/2003
5	Ligation 01/2020 - 06/2003
4	Immunotherapy 01/2022 - 11/2011
2	Laparotomy 03/2008 - 10/2006
2	Resuscitation 03/2008 - 10/2006
1	Oncolytic Virotherapy 09/2022
1	Transplantation 01/2021